Trial intelligence / Profile preview

Efficacy of deferoxamine + deferiprone on cardiac function in thalassemia major

IRCT2014070512765N4Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of deferoxamine and deferiprone in beta thalassemia major, sponsored by Golestan University of Medical Sciences. Started Feb 2010; status: completed.

02

Drugs

deferoxaminedeferiprone
03

Conditions

beta thalassemia major

Beyond the preview

Go deeper on IRCT2014070512765N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014070512765N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call